Quanta BioDesign

Quanta BioDesign is the inventor of discrete polyethylene glycol (dPEG®) technology, used for designing advanced bioconjugates and payload delivery in life science and biopharmaceutical applications. Quanta BioDesign has developed patented and innovative crosslinking and labeling chemistries that incorporate its dPEG technology and are enabled by its unique expertise, offering new approaches in the field of therapeutic and diagnostic development.